- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Weekly Round-Up: Shoppers Drug Mart Closes Medical Cannabis Store
A leading pharmacy chain in Canada is leaving the cannabis space as it transitions patients to a new platform run by Avicanna.
Shoppers Drug Mart, a Canadian pharmacy chain owned by Loblaw Companies (TSX:L,OTC Pink:LBLCF), announced this week that it is getting out of the medical cannabis dispensing industry.
Also in Canada, the cannabis industry was hoping for some relief from the country's new federal budget. However, after it was unveiled, a business association called it out for not doing enough for the sector.
Keep reading to find out about cannabis highlights from the past five days.
Shoppers Drug Mart to transition patients to new platform
Shoppers announced on Tuesday (March 28) that it will wind down its online medical cannabis platform in the next three months.
Canadian medical cannabis patients relying on the digital storefront set up by the nationwide pharmacy chain will now be counting on Avicanna’s (TSX:AVCN,OTCQX:AVCNF) platform MyMedi.ca.
"We are motivated towards furthering the work started by Shoppers Drug Mart to create Canada's leading independent, comprehensive medical cannabis platform and continuing our efforts towards advancing access to medical cannabis and its long-term incorporation into the standard of care," Aras Azadian, CEO of Avicanna, said.
The launch of Shoppers' medical cannabis platform was seen as a recognition of the industry’s size and potential following the legalization of adult-use products in late 2018. According to the company, it supported tens of thousands of patients.
While Shoppers hasn't given an explanation for its decision to step away from the cannabis space, President Jeff Leger said the company will continue to advocate for the belief that cannabis medication “should be dispensed in pharmacies like all others.”
Canada's federal budget changes tax payment schedule
The delivery of Canada's latest federal budget brought another major change in the country's cannabis market.
While some of the industry's longstanding requests for financial help weren't addressed, the document acknowledges the sector in one significant way by announcing that cannabis excise duty payment terms will change from monthly to quarterly.
A leading association representing the interests of Canadian licensed producers wasn’t impressed by the rule change.
“The survival of our industry’s small and medium sized players hangs in the balance, and the measure announced today and the words acknowledging the challenging conditions that we face don’t add up to meaningful relief,” George Smitherman, president and CEO of the Cannabis Council of Canada, said in a statement.
According to the group, cannabis sales in Canada earned governments C$1.6 billion in the 2021/2022 fiscal year.
Cannabis company news
- Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF)confirmed the launch of an online marketplace in Apple's (NASDAQ:AAPL) App Store. Matthew Hollingshead, chief innovation officer with the retailer, said this service will engage consumers on a new level.
- Auxly Cannabis Group (TSX:XLY,OTCQB:CBWTF)issued its Q4 and full-year financial results for 2022 and provided an outlook for the coming year. Hugo Alves, CEO of Auxly, said the company has had to adapt because of the challenges facing the Canadian cannabis industry. “Our efforts have yielded positive results, including our first significant wholesales of bulk dried flower from Auxly Leamington, improved net revenues and blended margins, and reductions in SG&A during the fourth quarter,” he said.
- High Tide (NASDAQ:HITI,TSXV:HITI)confirmed to investors the purchase of 258,921 common shares of the firm by a group of “certain officers, directors and consultants," led by the president and CEO, at an average price of US$1.59 per share. Insiders now own approximately 9.67 percent of the company’s shares.
- Verano Holdings (CSE:VRNO,OTCQX:VRNOF)released its financial results for Q4 2022 as well as the full year. “I’m very proud of our results in 2022, highlighted by record revenue and one of the industry’s leading margin profiles, which demonstrate our continued execution in driving efficiencies across the business and positioning ourselves ahead of growth,” said George Archos, founder, chairman and CEO of the firm.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
The Beginner’s Guide to Investing in Biotech
Ready to invest in biotech? Our beginner's guide makes it simple to get started.
Download your investing guide today.
Learn About Exciting Investing Opportunities in the Biotech Sector
Your Newsletter Preferences
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Bryan is a Senior Editor with INN. After graduating from the Langara journalism program he did some freelance reporting with community newspapers in British Columbia. He initially wrote about the life science space for INN and now spends his time covering the marijuana market, from Canadian LPs to US-based companies, and the impact of this sector on investors.
Learn about our editorial policies.